CTRI/2020/07/026502尚未招募未知
Surfactant with budesonide in reducing duration of respiratory support and respiratory morbidity in preterm neonates less than 32 weeks: Open labelled randomized controlled trial
Munmun Sahney0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Receiving mechanical ventilation via an endotracheal tube, or infants receiving non-invasive respiratory support including continuous positive airway pressure (CPAP), non-invasive intermittent positive pressure ventilation (NIPPV) or nasal high flow (HF), and a clinical decision to treat the infant with exogenous surfactant.
排除标准
- •1. Infant is considered non-viable (less than 23 weeks) or is not going to be admitted to the neonatal intensive care unit (NICU)
- •2. Known or suspected major congenital anomaly that are likely to affect respiratory status (upper airway obstruction, severe pulmonary hypoplasia following oligohydramnios, congenital lung malformation, and major congenital heart disease)
研究者
相似试验
招募中
3 期
Effect of Budesonide with Surfactant on the prevention of chronic lung disease in premature infantsIRCT20171030037093N38Esfahan University of Medical Sciences190
招募中
2 期
Comparision of surfactant and surfactant with budesonide to reduce the incidence of chronic lung disease in a very preterm newborns - a randomised control trialCTRI/2024/04/065406Shaik Mohammed Munthakheem
招募中
不适用
sing a tracker incorporated into Budesonide/Formoterol turbuhaler to improve asthma control: a randomized controlled studyPatients with moderate to severe asthma with/without turbuhaler-incorporated tracker to assist asthma controlJPRN-UMIN000042690Taipei Veterans General Hospital74
尚未招募
不适用
Effect of adding steroids to routine treatment in managing preterm babies with respiratory distressCTRI/2021/01/030392Susmitha Tangirala
已完成
3 期
Administration of budesonide with surfactant and prevention of bronchopulmonary dysplasiaIRCT20100512003915N20Tabriz University of Medical Sciences128